Biotechnology (146) | Severance Agreements (146)
Browse by Company
-
2seventy bio, Inc.
(1 contract)
-
Acorda Therapeutics
(1)
-
Adamas Pharmaceuticals Inc
(1)
-
Adaptimmune Therapeutics PLC
(1)
-
ADURO BIOTECH, INC.
(1)
-
Aeglea BioTherapeutics, Inc.
(2)
-
AGIOS PHARMACEUTICALS INC
(1)
-
AILERON THERAPEUTICS INC
(5)
-
AKCEA THERAPEUTICS, INC.
(8)
-
Aptevo Therapeutics Inc.
(1)
-
Aravive, Inc.
(2)
-
Arbutus Biopharma Corp
(1)
-
Arcturus Therapeutics Holdings Inc.
(1)
-
ARENA PHARMACEUTICALS INC
(7)
-
ARYA Sciences Acquisition Corp II
(1)
-
Avid Bioservices, Inc.
(1)
-
BioAtla, Inc.
(4)
-
Biogen Inc.
(2)
-
Bolt Biotherapeutics, Inc.
(1)
-
Calithera Biosciences, Inc.
(1)
-
Calyxt, Inc.
(3)
-
CATABASIS PHARMACEUTICALS INC
(2)
-
CHIMERIX INC
(1)
-
Codiak BioSciences, Inc.
(1)
-
Conatus Pharmaceuticals Inc.
(1)
-
Cortexyme, Inc.
(2)
-
CTI BIOPHARMA CORP
(2)
-
Cyclerion Therapeutics, Inc.
(2)
-
DYNAVAX TECHNOLOGIES CORP
(2)
-
Dyne Therapeutics, Inc.
(1)
-
Eagle Pharmaceuticals, Inc.
(2)
-
Editas Medicine, Inc.
(2)
-
Evelo Biosciences, Inc.
(2)
-
EXACT SCIENCES CORP
(1)
-
FIVE PRIME THERAPEUTICS INC
(3)
-
FS Development Corp. II
(1)
-
Generation Bio Co.
(1)
-
GERON CORP
(2)
-
Gilead Sciences
(5)
-
Graphite Bio, Inc.
(1)
-
HALOZYME THERAPEUTICS INC
(1)
-
IMMUCELL CORP
(1)
-
IMMUNOGEN INC
(1)
-
IONIS PHARMACEUTICALS INC
(1)
-
IOVANCE BIOTHERAPEUTICS, INC.
(1)
-
IRONWOOD PHARMACEUTICALS INC
(4)
-
Karyopharm Therapeutics Inc.
(2)
-
Kindred Biosciences, Inc.
(1)
-
LEXICON PHARMACEUTICALS, INC.
(2)
-
Ligand Pharmaceuticals Incorporated
(2)
-
Lyell Immunopharma, Inc.
(3)
-
MAXCYTE, INC.
(5)
-
Metacrine, Inc.
(1)
-
MiMedx Group, Inc.
(1)
-
Mirum Pharmaceuticals, Inc.
(1)
-
Moderna, Inc.
(1)
-
Morphic Holding, Inc.
(1)
-
Nkarta, Inc.
(1)
-
Ophthotech Corp.
(1)
-
Opko Health, Inc.
(1)
-
PDL BIOPHARMA, INC.
(4)
-
PhaseBio Pharmaceuticals Inc
(1)
-
PROGENITY, INC.
(2)
-
Protagonist Therapeutics, Inc
(4)
-
Radius Health, Inc.
(1)
-
Reneo Pharmaceuticals, Inc.
(4)
-
RIGEL PHARMACEUTICALS INC
(1)
-
SANGAMO THERAPEUTICS, INC
(1)
-
Sarepta Therapeutics, Inc.
(1)
-
Sigilon Therapeutics, Inc.
(2)
-
SUNESIS PHARMACEUTICALS INC
(2)
-
Tracon Pharmaceuticals, Inc.
(3)
-
Turning Point Therapeutics, Inc.
(6)
-
Viela Bio, Inc.
(1)
-
VITAL THERAPIES INC
(1)
Recent Contracts
-
Severance Agreement, dated February 13, 2023, by and between Evelo Biosciences, Inc. and Jonathan Zung
(Evelo Biosciences, Inc., Filed With SEC on March 16, 2023)
-
Severance Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated February 17, 2023
(2seventy bio, Inc., Filed With SEC on March 16, 2023)
-
Severance Agreement, dated March 8, 2017, between the Registrant and Ron Holtz
(MAXCYTE, INC., Filed With SEC on March 15, 2023)
-
Severance Agreement, by and between Protagonist Therapeutics Inc. and Arturo Molina, M.D., Ph.D., dated November 7, 2022
(Protagonist Therapeutics, Inc, Filed With SEC on March 15, 2023)
-
Severance Agreement by and between the Registrant and Bonne Adams, dated September 27, 2017
(Tracon Pharmaceuticals, Inc., Filed With SEC on March 8, 2023)
-
Amended and Restated Severance Plan, effective November 1, 2022
(Ligand Pharmaceuticals Incorporated, Filed With SEC on February 28, 2023)
-
Severance Agreement, effective December 5, 2022, by and between Ligand Pharmaceuticals Incorporated and Todd C. Davis
(Ligand Pharmaceuticals Incorporated, Filed With SEC on February 28, 2023)
-
Amended and Restated Executive Severance Plan and Form of Participation Letter, as amended on February
(Moderna, Inc., Filed With SEC on February 24, 2023)
-
Amendment to Calyxts 2021 Executive Severance Plan
(Calyxt, Inc., Filed With SEC on January 17, 2023)
-
Executive Severance Plan adopted December 5, 2022
(Avid Bioservices, Inc., Filed With SEC on December 9, 2022)
